Status:
COMPLETED
Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Lead Sponsor:
Children's Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Recurrent Adult Acute Lymphoblastic Leukemia
Recurrent Adult Non-Hodgkin Lymphoma
Eligibility:
All Genders
Up to 30 years
Brief Summary
This research study is collecting and storing samples of bone marrow and blood from patients with relapsed acute lymphoblastic leukemia or relapsed non-Hodgkin lymphoma. Collecting and storing samples...
Detailed Description
OBJECTIVES: I. Establish a mechanism to bank specimens of tumor cells and host germline DNA from patients with acute lymphoblastic leukemia (ALL) at first and subsequent relapse. II. Make these spec...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosis of acute lymphoblastic leukemia (ALL) or prior history of non-Hodgkin lymphoma
- In first or subsequent marrow relapse with ≥ 25% blasts in bone marrow and/or peripheral blood
- Bone marrow and/or peripheral blood samples (≥ 5 mL) required at the time of diagnosis of relapse
- No concurrent systemic antileukemic treatment administered for current relapse
- Intrathecal chemotherapy allowed
- On-therapy relapse allowed
Exclusion
Key Trial Info
Start Date :
September 25 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
811 Patients enrolled
Trial Details
Trial ID
NCT00897325
Start Date
September 25 2006
End Date
December 31 2019
Last Update
January 18 2020
Active Locations (183)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Alabama
Birmingham, Alabama, United States, 35233
2
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States, 35233
3
Phoenix Childrens Hospital
Phoenix, Arizona, United States, 85016
4
Banner University Medical Center - Tucson
Tucson, Arizona, United States, 85719